3-187042942-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173216.2(ST6GAL1):c.239G>A(p.Ser80Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173216.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST6GAL1 | NM_173216.2 | c.239G>A | p.Ser80Asn | missense_variant | Exon 4 of 8 | ENST00000169298.8 | NP_775323.1 | |
ST6GAL1 | NM_001353916.2 | c.239G>A | p.Ser80Asn | missense_variant | Exon 2 of 6 | NP_001340845.1 | ||
ST6GAL1 | NM_003032.3 | c.239G>A | p.Ser80Asn | missense_variant | Exon 3 of 7 | NP_003023.1 | ||
ST6GAL1 | NM_173217.2 | c.-87+4069G>A | intron_variant | Intron 3 of 6 | NP_775324.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250916 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74366 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.239G>A (p.S80N) alteration is located in exon 4 (coding exon 1) of the ST6GAL1 gene. This alteration results from a G to A substitution at nucleotide position 239, causing the serine (S) at amino acid position 80 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at